PLUS THERAPEUTICS, INC. — Director's Dealing 2014

Jul 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2014-07-01

Reporting Person: Naughton Gail K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-01	Restricted Stock Award	A	21000	$0.00	Acquired	21000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-01	Non Qualified Stock Option (Right to Buy)	$2.40	A	21000	Acquired	2024-07-01	Common Stock (21000)	Direct

Footnotes

F1: The Restricted Stock vests 50% on July 1, 2015 and 50% on July 1, 2016, subject to Dr. Naughton's continued service to the Company.

F2: The option vests 50% on July 1, 2015 with the remaining options vesting in equal monthly installments over the subsequent year thereafter, subject to Dr. Naughton's continued service to the Company.